Preprint · 2021 · Open access
Adaptive Approval of Drugs for Rare Diseases
SSRN Electronic Journal · Published 1 January 2021 · DOI 10.2139/ssrn.3928811
In brief
“Adaptive Approval of Drugs for Rare Diseases” is a 2021 preprint by Wendy Olsder and 2 co-authors, published in SSRN Electronic Journal. OpenAlex counts 0 citations as of 19 November 2026. It is open access: the full text is free to read at SSRN Electronic Journal.
- Citations
- 0
- References
- 25
- Authors
- 3
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Olsder, W., Martagan, T., & Fransoo, J. C. (2021). Adaptive Approval of Drugs for Rare Diseases. SSRN Electronic Journal. https://doi.org/10.2139/ssrn.3928811
MLA 9
Olsder, Wendy, et al. “Adaptive Approval of Drugs for Rare Diseases.” SSRN Electronic Journal, 2021. https://doi.org/10.2139/ssrn.3928811.
Chicago
Olsder, Wendy, Tugce Martagan, and Jan C. Fransoo. 2021. “Adaptive Approval of Drugs for Rare Diseases.” SSRN Electronic Journal. https://doi.org/10.2139/ssrn.3928811.
Harvard
Olsder, W., Martagan, T. and Fransoo, J. C. (2021) ‘Adaptive Approval of Drugs for Rare Diseases’, SSRN Electronic Journal. doi:10.2139/ssrn.3928811.
IEEE
W. Olsder, T. Martagan, and J. C. Fransoo, “Adaptive Approval of Drugs for Rare Diseases,” SSRN Electronic Journal, 2021, doi: 10.2139/ssrn.3928811.
BibTeX
@misc{olsder2021adaptive,
title = {{Adaptive Approval of Drugs for Rare Diseases}},
author = {Olsder, Wendy and Martagan, Tugce and Fransoo, Jan C.},
howpublished = {SSRN Electronic Journal},
year = {2021},
doi = {10.2139/ssrn.3928811},
url = {https://doi.org/10.2139/ssrn.3928811}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy
- rare diseases
- unmet clinical needs
- pharmaceutical industry incentives
- Stackelberg game
- subsidies
- exit strategy
- market exclusivity
- R&D investment
Work with this paper
Most-cited papers in Economics, Econometrics and Finance
- Theory of the firm: Managerial behavior, agency costs and ownership structureMichael C. Jensen, William H. Meckling · Journal of Financial Economics · 1976 · 77,585 citations
- Institutions, Institutional Change and Economic PerformanceDouglass C. North · Cambridge University Press eBooks · 1990 · 34,377 citations
- The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.John E. Ware, Cathy Donald Sherbourne · PubMed · 1992 · 33,943 citations
- Some Tests of Specification for Panel Data: Monte Carlo Evidence and an Application to Employment EquationsManuel Arellano, Stephen R. Bond · The Review of Economic Studies · 1991 · 33,778 citations
- Co-Integration and Error Correction: Representation, Estimation, and TestingRobert F. Engle, C.W.J. Granger · Econometrica · 1987 · 32,847 citations
Questions about this paper
How do I cite this paper in APA style?
Olsder, W., Martagan, T., & Fransoo, J. C. (2021). Adaptive Approval of Drugs for Rare Diseases. SSRN Electronic Journal. https://doi.org/10.2139/ssrn.3928811
How many times has this paper been cited?
0 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at SSRN Electronic Journal: sign in and open the full text from this page.
Who wrote this paper?
Wendy Olsder, Tugce Martagan, Jan C. Fransoo.
What is the DOI of this paper?
10.2139/ssrn.3928811, permanently at https://doi.org/10.2139/ssrn.3928811. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.